Kendric Speagle, CEO, and Kate Fassett, Chief Development Officer of VivaMed BioPharma, talk to our hosts about AI-powered drug discovery, repurposing existing drugs to accelerate treatment development, reducing the cost and timeline of bringing therapies to market, and advancing innovative solutions for chronic diseases and unmet medical needs.
February 7, 2023
